Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tucker

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|April 12, 2014
Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry studyElisa Calzolari, Ingeborg Barisic, Maria Loane, et al.
British Journal of Clinical Pharmacology|March 31, 2016
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsJoanne E Given, Maria Loane, Johannes M Luteijn, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screeningMaria Loane, Joan K Morris, Marie-Claude Addor, et al.
Orphanet Journal of Rare Diseases|October 26, 2014
Holt Oram syndrome: a registry-based study in EuropeIngeborg Barisic, Ljubica Boban, Ruth Greenlees, et al.
Paediatric and Perinatal Epidemiology|November 24, 2025
Genetic Diagnoses Among Congenital Anomaly Cases in Europe: Data From the EUROCAT NetworkJorieke E H Bergman, Annie Perraud, Ester Garne, et al.
Paediatric and Perinatal Epidemiology|February 27, 2020
Multilevel analyses of related public health indicators: The European Surveillance of Congenital Anomalies (EUROCAT) Public Health IndicatorsKate E Best, Judith Rankin, Helen Dolk, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Pediatrics|February 11, 2022
Ten-Year Survival of Children With Congenital Anomalies: A European Cohort StudySvetlana V Glinianaia, Judith Rankin, Anna Pierini, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Pharmacoepidemiology and Drug Safety|April 30, 2026
The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in PregnancyHelen Dolk, Christine Damase-Michel, Joan Morris, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Birth Defects Research. Part A, Clinical and Molecular Teratology|April 12, 2014
Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry studyElisa Calzolari, Ingeborg Barisic, Maria Loane, et al.
British Journal of Clinical Pharmacology|March 31, 2016
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsJoanne E Given, Maria Loane, Johannes M Luteijn, et al.
European Journal of Human Genetics : EJHG|June 21, 2012
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screeningMaria Loane, Joan K Morris, Marie-Claude Addor, et al.
Orphanet Journal of Rare Diseases|October 26, 2014
Holt Oram syndrome: a registry-based study in EuropeIngeborg Barisic, Ljubica Boban, Ruth Greenlees, et al.
Paediatric and Perinatal Epidemiology|November 24, 2025
Genetic Diagnoses Among Congenital Anomaly Cases in Europe: Data From the EUROCAT NetworkJorieke E H Bergman, Annie Perraud, Ester Garne, et al.
Paediatric and Perinatal Epidemiology|February 27, 2020
Multilevel analyses of related public health indicators: The European Surveillance of Congenital Anomalies (EUROCAT) Public Health IndicatorsKate E Best, Judith Rankin, Helen Dolk, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Pediatrics|February 11, 2022
Ten-Year Survival of Children With Congenital Anomalies: A European Cohort StudySvetlana V Glinianaia, Judith Rankin, Anna Pierini, et al.
British Journal of Haematology|May 7, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysisAlexandros Rampotas, Matthew R Wilson, Oliver Lomas, et al.
Pharmacoepidemiology and Drug Safety|April 30, 2026
The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in PregnancyHelen Dolk, Christine Damase-Michel, Joan Morris, et al.
Pageof 13